Series C Funded Startups in United Kingdom
The largest disclosed Series C in this UK snapshot is Wayve at $1.1B (2024-05-07), which dwarfs the next-largest disclosed rounds such as Flo Health at $20…
The largest disclosed Series C in this UK snapshot is Wayve at $1.1B (2024-05-07), which dwarfs the next-largest disclosed rounds such as Flo Health at $200M (2024-07-30), Nothing at $200M (2025-09-20), and Dexory at $100M (2025-10-15). By contrast, the smallest disclosed amount among disclosed rounds is $10M for Winnow (2023-06-13), with several other smaller disclosed checks clustering in the teens to $50M range (e.g., Brainomix $18M on 2025-03-18; Perspectum $19M on 2023-03-15).
Geographically, London dominates: repeated London-based entries include Fnality International ($136M, 2025-09-26), Luminance ($75M, 2025-02-18 is Cambridge), and Copper ($181M, 2022-10-12), while non-London hubs recur with Cambridge (e.g., CellCentric $120M, 2025-05-19; Riverlane $75M, 2024-08-06). Temporally, the rounds span 2022-10-10 (Connex One) through 2025-10-15 (Dexory), and the dataset includes two “undisclosed” disclosed amounts (Leo Cancer Care on 2024-06-11 and ENOUGH on 2024-02-15).
Most recent rounds
50 shownRelated listings
Frequently asked
Which company has the biggest disclosed Series C here, and how extreme is it versus the rest of the disclosed amounts?
Wayve’s $1.1B Series C (2024-05-07) is an outlier: other large disclosed rounds are far lower, including Nothing’s $200M (2025-09-20) and Flo Health’s $200M (2024-07-30). The lowest disclosed amount is Winnow’s $10M (2023-06-13), indicating a wide dispersion from $10M upward among disclosed rows.
Do London-based companies cluster by sector more than other cities in this list?
London is repeatedly represented across sectors, including financial services (Fnality International $136M on 2025-09-26; Allica Bank $122M on 2022-12-05), AI/software-adjacent themes (Dexory $100M on 2025-10-15; Synthesia $90M on 2023-06-13), and commerce/commerce-adjacent plays (Dropit Shopping $25M on 2022-11-03). Cambridge and Oxford show more concentration within biotech/hardware/AI (e.g., CellCentric $120M, 2025-05-19; Osler Diagnostics $85M, 2022-11-07; Oxbotica $140M, 2023-01-10).
Are there any distinct temporal waves in the most recent period shown (for example, within the last ~12 months)?
The most recent closes span late 2025 through 2024, with multiple 2025 rounds concentrated in the first half of the year’s tail (e.g., Dexory 2025-10-15, Fnality International 2025-09-26, Nothing 2025-09-20, and CellCentric 2025-05-19). In 2024, there is also a busy late-2024 window with several entries in Sep–Oct 2024, such as Datamaran $33M (2024-09-19) and Nuclera $75M (2024-10-15).
How often is funding amount missing in this dataset, and do those “undisclosed” rounds change how comparisons should be made?
Two rows are explicitly “undisclosed” (Leo Cancer Care on 2024-06-11 and ENOUGH on 2024-02-15). Comparisons that rely on largest/smallest disclosed amounts are therefore based only on the remaining disclosed entries rather than treating those as unknown values.
Which sector shows the most repeated representation across these Series C rounds?
Artificial Intelligence (AI) appears most frequently in the list, spanning companies such as Dexory (2025-10-15, $100M), Brainomix (2025-03-18, $18M), Healx (2024-08-01, $47M), Synthesia (2023-06-13, $90M), and Wayve (2024-05-07, $1.1B). Several other sectors repeat too (e.g., Financial Services and Hardware), but AI is the clearest multi-entry cluster by label within the shown rows.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.